Migratory Strategies of Normal and Malignant Stem Cells

Methods in Molecular Biology

Volumn 750, Issue , 2011, Pages 25-44

  Hess, David A ^b   Allan, Alison L ^a  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b NONE

Author keywords

Adhesion; Adult stem cells; Cancer stem cells; CD44; Epithelial to mesenchymal transition; Homing chemotaxis; Metastasis; Niche specificity; SDF 1 CXCR 4 axis

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HERMES ANTIGEN; STROMAL CELL DERIVED FACTOR 1;

ADULT STEM CELL; ANIMAL; ARTICLE; BONE MARROW; CANCER STEM CELL; CELL ADHESION; CELL COUNT; CELL MOTION; CYTOLOGY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; PATHOLOGY; PHYSIOLOGY; REGENERATION; SIGNAL TRANSDUCTION; STEM CELL MOBILIZATION;

ADULT STEM CELLS; ANIMALS; ANTIGENS, CD44; BONE MARROW; CELL ADHESION; CELL COUNT; CELL MOVEMENT; CHEMOKINE CXCL12; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STEM CELLS; MICE; MOLECULAR TARGETED THERAPY; NEOPLASTIC STEM CELLS; RECEPTORS, CXCR4; REGENERATION; SIGNAL TRANSDUCTION;

EID: 80052631487     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-145-1_2     Document Type: Chapter

References (135)

1. Weissman, I. L. (2000) Stem cells: units of development, units of regeneration, and units in evolution Cell 100, 157–68.
2. Laird, D. J., von Andrian, U. H., and Wagers, A. J. (2008) Stem cell trafficking in tissue development, growth, and disease Cell 132, 612–30.
3. Morrison, S. J. and Spradling, A. C. (2008) Stem cells and niches: mechanisms that promote stem cell maintenance throughout life Cell 132, 598–611.
4. Massberg, S., Schaerli, P., Knezevic-Maramica, I., Kollnberger, M., Tubo, N., Moseman, E. A., Huff, I. V., Junt, T., Wagers, A. J., Mazo, I. B., and von Andrian, U. H. (2007) Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues Cell 131, 994–1008.
5. Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., Witzenbichler, B., Schatteman, G., and Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis Science 275, 964–7.
6. Yoder, M. C., Mead, L. E., Prater, D., Krier, T. R., Mroueh, K. N., Li, F., Krasich, R., Temm, C. J., Prchal, J. T., and Ingram, D. A. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood 109, 1801–9.
7. Crisan, M., Yap, S., Casteilla, L., Chen, C. W., Corselli, M., Park, T. S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C., Teng, P. N., Traas, J., Schugar, R., Deasy, B. M., Badylak, S., Buhring, H. J., Giacobino, J. P., Lazzari, L., Huard, J., and Peault, B. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs Cell Stem Cell 3, 301–13.
8. Uccelli, A., Moretta, L., and Pistoia, V. (2008) Mesenchymal stem cells in health and disease Nat Rev Immunol.
9. Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C., and Moretta, L. (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2 Blood 111, 1327–33.
10. Au, P., Tam, J., Fukumura, D., and Jain, R. K. (2008) Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature Blood 111, 4551–8.
11. Hess, D., Li, L., Martin, M., Sakano, S., Hill, D., Strutt, B., Thyssen, S., Gray, D. A., and Bhatia, M. (2003) Bone marrow-derived stem cells initiate pancreatic regeneration Nat Biotechnol 21, 763–70.
12. Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., and Prockop, D. J. (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice Proc Natl Acad Sci USA 103, 17438–43.
13. Zhou, P., Hohm, S., Capoccia, B., Wirthlin, L., Hess, D., Link, D., and Nolta, J. (2008) Immunodeficient mouse models to study human stem cell-mediated tissue repair Methods Mol Biol 430, 213–25.
14. Kaplan, R. N., Rafii, S., and Lyden, D. (2006) Preparing the “soil”: the premetastatic niche Cancer Res 66, 11089–93.
15. Avecilla, S. T., Hattori, K., Heissig, B., Tejada, R., Liao, F., Shido, K., Jin, D. K., Dias, S., Zhang, F., Hartman, T. E., Hackett, N. R., Crystal, R. G., Witte, L., Hicklin, D. J., Bohlen, P., Eaton, D., Lyden, D., de Sauvage, F., and Rafii, S. (2004) Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis Nat Med 10, 64–71.
16. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., and Rafii, S. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand Cell 109, 625–37.
17. Heissig, B., Ohki, Y., Sato, Y., Rafii, S., Werb, Z., and Hattori, K. (2005) A role for niches in hematopoietic cell development Hematology 10, 247–53.
18. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., Tesio, M., Samstein, R. M., Goichberg, P., Spiegel, A., Elson, A., and Lapidot, T. (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells Nat Med 12, 657–64.
19. Broxmeyer, H. E., Hangoc, G., Cooper, S., Campbell, T., Ito, S., and Mantel, C. (2007) AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis Ann N Y Acad Sci 1106, 1–19.
20. Campbell, T. B., Hangoc, G., Liu, Y., Pollok, K., and Broxmeyer, H. E. (2007) Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese dia-betic/severe combined immunodeficiency mice Stem Cells Dev 16, 347–54.
21. Christopherson, K. W., 2nd, Hangoc, G., and Broxmeyer, H. E. (2002) Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells J Immunol 169, 7000–8.
22. Christopherson, K. W., 2nd, Hangoc, G., Mantel, C. R., and Broxmeyer, H. E. (2004) Modulation of hematopoietic stem cell homing and engraftment by CD26 Science 305, 1000–3.
23. Stier, S., Ko, Y., Forkert, R., Lutz, C., Neuhaus, T., Grunewald, E., Cheng, T., Dombkowski, D., Calvi, L. M., Rittling, S. R., and Scadden, D. T. (2005) Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size J Exp Med 201, 1781–91.
24. Calvi, L. M., Adams, G. B., Weibrecht, K. W., Weber, J. M., Olson, D. P., Knight, M. C., Martin, R. P., Schipani, E., Divieti, P., Bringhurst, F. R., Milner, L. A., Kronenberg, H. M., and Scadden, D. T. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche Nature 425, 841–6.
25. Levesque, J. P., Hendy, J., Winkler, I. G., Takamatsu, Y., and Simmons, P. J. (2003) Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells Exp Hematol 31, 109–17.
26. Levesque, J. P., Hendy, J., Takamatsu, Y., Simmons, P. J., and Bendall, L. J. (2003) Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclo-phosphamide J Clin Invest 111, 187–96.
27. Liles, W. C., Broxmeyer, H. E., Rodger, E., Wood, B., Hubel, K., Cooper, S., Hangoc, G., Bridger, G. J., Henson, G. W., Calandra, G., and Dale, D. C. (2003) Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist Blood 102, 2728–30.
28. Broxmeyer, H. E., Orschell, C. M., Clapp, D. W., Hangoc, G., Cooper, S., Plett, P. A., Liles, W. C., Li, X., Graham-Evans, B., Campbell, T. B., Calandra, G., Bridger, G., Dale, D. C., and Srour, E. F. (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist J Exp Med 201, 1307–18.
29. Hess, D. A., Bonde, J., Craft, T. P., Wirthlin, L., Hohm, S., Lahey, R., Todt, L. M., Dipersio, J. F., Devine, S. M., and Nolta, J. A. (2007) Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor Biol Blood Marrow Transplant 13, 398–411.
30. Shepherd, R. M., Capoccia, B. J., Devine, S. M., Dipersio, J., Trinkaus, K. M., Ingram, D., and Link, D. C. (2006) Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100 Blood 108, 3662–7.
31. Capoccia, B. J., Shepherd, R. M., and Link, D. C. (2006) G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism Blood 108, 2438–45.
32. Pitchford, S. C., Furze, R. C., Jones, C. P., Wengner, A. M., and Rankin, S. M. (2009) Differential mobilization of subsets of progenitor cells from the bone marrow Cell Stem Cell 4, 62–72.
33. Broxmeyer, H. E., Kohli, L., Kim, C. H., Lee, Y., Mantel, C., Cooper, S., Hangoc, G., Shaheen, M., Li, X., and Clapp, D. W. (2003) Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells J Leukoc Biol 73, 630–8.
34. Broxmeyer, H. E., Cooper, S., Kohli, L., Hangoc, G., Lee, Y., Mantel, C., Clapp, D. W., and Kim, C. H. (2003) Transgenic expression of stromal cell-derived factor-1/ CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo J Immunol 170, 421–9.
35. Lee, Y., Gotoh, A., Kwon, H. J., You, M., Kohli, L., Mantel, C., Cooper, S., Hangoc, G., Miyazawa, K., Ohyashiki, K., and Broxmeyer, H. E. (2002) Enhancement of intracellular signaling associated with hematopoietic progenitor cell survival in response to SDF-1/CXCL12 in synergy with other cytokines Blood 99, 4307–17.
36. Jo, D. Y., Rafii, S., Hamada, T., and Moore, M. A. (2000) Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1 J Clin Invest 105, 101–11.
37. Naiyer, A. J., Jo, D. Y., Ahn, J., Mohle, R., Peichev, M., Lam, G., Silverstein, R. L., Moore, M. A., and Rafii, S. (1999) Stromal derived factor-1-induced chemokinesis of cord blood CD34(+) cells (long-term cul-ture-initiating cells) through endothelial cells is mediated by E-selectin Blood 94, 4011–9.
38. Mohle, R., Bautz, F., Rafii, S., Moore, M. A., Brugger, W., and Kanz, L. (1998) The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1 Blood 91, 4523–30.
39. Kollet, O., Petit, I., Kahn, J., Samira, S., Dar, A., Peled, A., Deutsch, V., Gunetti, M., Piacibello, W., Nagler, A., and Lapidot, T. (2002) Human CD34(+)CXCR4(−) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/ SCID repopulation Blood 100, 2778–86.
40. Kollet, O., Spiegel, A., Peled, A., Petit, I., Byk, T., Hershkoviz, R., Guetta, E., Barkai, G., Nagler, A., and Lapidot, T. (2001) Rapid and efficient homing of human CD34(+) CD38(−/low)CXCR4(+) stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2m(null) mice Blood 97, 3283–91.
41. Peled, A., Kollet, O., Ponomaryov, T., Petit, I., Franitza, S., Grabovsky, V., Slav, M. M., Nagler, A., Lider, O., Alon, R., Zipori, D., and Lapidot, T. (2000) The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice Blood 95, 3289–96.
42. Peled, A., Grabovsky, V., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Petit, I., Ben-Hur, H., Lapidot, T., and Alon, R. (1999) The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow J Clin Invest 104, 1199–211.
43. Peled, A., Petit, I., Kollet, O., Magid, M., Ponomaryov, T., Byk, T., Nagler, A., Ben-Hur, H., Many, A., Shultz, L., Lider, O., Alon, R., Zipori, D., and Lapidot, T. (1999) Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 Science 283, 845–8.
44. Hattori, K., Heissig, B., Tashiro, K., Honjo, T., Tateno, M., Shieh, J. H., Hackett, N. R., Quitoriano, M. S., Crystal, R. G., Rafii, S., and Moore, M. A. (2001) Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells Blood 97, 3354–60.
45. Lapidot, T., Dar, A., and Kollet, O. (2005) How do stem cells find their way home? Blood 106, 1901–10.
46. Ponomaryov, T., Peled, A., Petit, I., Taichman, R. S., Habler, L., Sandbank, J., Arenzana-Seisdedos, F., Magerus, A., Caruz, A., Fujii, N., Nagler, A., Lahav, M., Szyper-Kravitz, M., Zipori, D., and Lapidot, T. (2000) Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function J Clin Invest 106, 1331–9.
47. Zhao, Y., Zhan, Y., Burke, K. A., and Anderson, W. F. (2005) Soluble factor(s) from bone marrow cells can rescue lethally irradiated mice by protecting endogenous hematopoietic stem cells Exp Hematol 33, 428–34.
48. Kawabata, K., Ujikawa, M., Egawa, T., Kawamoto, H., Tachibana, K., Iizasa, H., Katsura, Y., Kishimoto, T., and Nagasawa, T. (1999) A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution Proc Natl Acad Sci USA 96, 5663–7.
49. Ma, Q., Jones, D., and Springer, T. A. (1999) The chemokine receptor CXCR4 is required for the retention of B lineage and granulo-cytic precursors within the bone marrow microenvironment Immunity 10, 463–71.
50. Kollet, O., Shivtiel, S., Chen, Y. Q., Suriawinata, J., Thung, S. N., Dabeva, M. D., Kahn, J., Spiegel, A., Dar, A., Samira, S., Goichberg, P., Kalinkovich, A., Arenzana-Seisdedos, F., Nagler, A., Hardan, I., Revel, M., Shafritz, D. A., and Lapidot, T. (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver J Clin Invest 112, 160–9.
51. Ratajczak, M. Z., Kucia, M., Reca, R., Majka, M., Janowska-Wieczorek, A., and Ratajczak, J. (2004) Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells ‘hide out’ in the bone marrow Leukemia 18, 29–40.
52. Stumm, R. K., Rummel, J., Junker, V., Culmsee, C., Pfeiffer, M., Krieglstein, J., Hollt, V., and Schulz, S. (2002) A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia J Neurosci 22, 5865–78.
53. Petit, I., Goichberg, P., Spiegel, A., Peled, A., Brodie, C., Seger, R., Nagler, A., Alon, R., and Lapidot, T. (2005) Atypical PKC-zeta regulates SDF-1-mediated migration and development of human CD34+ progenitor cells J Clin Invest 115, 168–76.
54. Cancelas, J. A., Lee, A. W., Prabhakar, R., Stringer, K. F., Zheng, Y., and Williams, D. A. (2005) Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization Nat Med 11, 886–91.
55. Gu, Y., Filippi, M. D., Cancelas, J. A., Siefring, J. E., Williams, E. P., Jasti, A. C., Harris, C. E., Lee, A. W., Prabhakar, R., Atkinson, S. J., Kwiatkowski, D. J., and Williams, D. A. (2003) Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases Science 302, 445–9.
56. Brooke, G., Tong, H., Levesque, J. P., and Atkinson, K. (2008) Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta Stem Cells Dev 17, 929–40.
57. Uccelli, A., Moretta, L., and Pistoia, V. (2008) Mesenchymal stem cells in health and disease Nat Rev Immunol 8, 726–36.
58. Hung, S. C., Pochampally, R. R., Hsu, S. C., Sanchez, C., Chen, S. C., Spees, J., and Prockop, D. J. (2007) Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo PLoS ONE 2, e416.
59. Ruster, B., Gottig, S., Ludwig, R. J., Bistrian, R., Muller, S., Seifried, E., Gille, J., and Henschler, R. (2006) Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells Blood 108, 3938–44.
60. Sordi, V., Malosio, M. L., Marchesi, F., Mercalli, A., Melzi, R., Giordano, T., Belmonte, N., Ferrari, G., Leone, B. E., Bertuzzi, F., Zerbini, G., Allavena, P., Bonifacio, E., and Piemonti, L. (2005) Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets Blood 106, 419–27.
61. Son, B. R., Marquez-Curtis, L. A., Kucia, M., Wysoczynski, M., Turner, A. R., Ratajczak, J., Ratajczak, M. Z., and Janowska-Wieczorek, A. (2006) Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth fac-tor-c-met axes and involves matrix metallo-proteinases Stem Cells 24, 1254–64.
62. Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., and Clarke, M. F. (2003) Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci USA 100, 3983–8.
63. Bonnet, D. and Dick, J. E. (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell Nat Med 3, 730–7.
64. Collins, A. T., Berry, P. A., Hyde, C., Stower, M. J., and Maitland, N. J. (2005) Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65, 10946–51.
65. Dalerba, P., Dylla, S. J., Park, I. K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., Shelton, A. A., Parmiani, G., Castelli, C., and Clarke, M. F. (2007) Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci USA 104, 10158–63.
66. Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M. J. J., Viens, P., Kleer, C. G., Liu, S., Schott, A., Hayes, D., Birnbaum, D., Wicha, M. S., and Dontu, G. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome Cell Stem Cell 1, 555–567.
67. Hermann, P. C., Huber, S. L., Herrler, T., Aicher, A., Ellwart, J. W., Guba, M., Bruns, C. J., and Heeschen, C. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer Cell Stem Cell 1, 313–323.
68. Hope, K. J., Jin, L., and Dick, J. E. (2004) Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity Nat Immunol 5, 738–43.
69. O’Brien, C. A., Pollett, A., Gallinger, S., and Dick, J. E. (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445, 106–10.
70. Prince, M. E., Sivanandan, R., Kaczorowski, A., Wolf, G. T., Kaplan, M. J., Dalerba, P., Weissman, I. L., Clarke, M. F., and Ailles, L. E. (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma Proc Natl Acad Sci USA 104, 973–8.
71. Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., and De Maria, R. (2007) Identification and expansion of human colon-cancer-initiating cells Nature 445, 111–5.
72. Schatton, T., Murphy, G. F., Frank, N. Y., Yamaura, K., Waaga-Gasser, A. M., Gasser, M., Zhan, Q., Jordan, S., Duncan, L. M., Weishaupt, C., Fuhlbrigge, R. C., Kupper, T. S., Sayegh, M. H., and Frank, M. H. (2008) Identification of cells initiating human melanomas Nature 451, 345–9.
73. Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H., Jones, D. L., Visvader, J., Weissman, I. L., and Wahl, G. M. (2006) Cancer Stem Cells--Perspectives on Current Status and Future Directions: AACR Workshop on Cancer Stem Cells Cancer Res 66, 9339–44.
74. Pardal, R., Clarke, M. F., and Morrison, S. J. (2003) Applying the principles of stem-cell biology to cancer Nat Rev Cancer 3, 895–902.
75. Bjerkvig, R., Tysnes, B. B., Aboody, K. S., Najbauer, J., and Terzis, A. J. (2005) Opinion: the origin of the cancer stem cell: current controversies and new insights Nat Rev Cancer 5, 899–904.
76. Al-Hajj, M. and Clarke, M. F. (2004) Self-renewal and solid tumor stem cells Oncogene 23, 7274–82.
77. Reya, T., Morrison, S. J., Clarke, M. F., and Weissman, I. L. (2001) Stem cells, cancer, and cancer stem cells Nature 414, 105–11.
78. Croker, A. K. and Allan, A. L. (2008) Cancer stem cells: implications for the progression and treatment of metastatic disease J Cell Mol Med 12, 374–90.
79. Hanahan, D. and Weinberg, R. A. (2000) The hallmarks of cancer Cell 100, 57–70.
80. Marx, J. (2003) Cancer research. Mutant stem cells may seed cancer Science 301, 1308–10.
81. Pereira, D. S., Dorrell, C., Ito, C. Y., Gan, O. I., Murdoch, B., Rao, V. N., Zou, J. P., Reddy, E. S., and Dick, J. E. (1998) Retroviral transduction of TLS-ERG initiates a leukemo-genic program in normal human hematopoietic cells Proc Natl Acad Sci USA 95, 8239–44.
82. Kelly, L. M. and Gilliland, D. G. (2002) Genetics of myeloid leukemias Annu Rev Genomics Hum Genet 3, 179–98.
83. Charafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M. H., Diebel, M. E., Monville, F., Dutcher, J., Brown, M., Viens, P., Xerri, L., Bertucci, F., Stassi, G., Dontu, G., Birnbaum, D., and Wicha, M. S. (2009) Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature Cancer Res 69, 1302–13.
84. Croker, A. K., Goodale, D., Chu, J., Postenka, C., Hedley, B. D., Hess, D. A., and Allan, A. L. (2008) High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability J Cell Mol Med.
85. Yu, F., Yao, H., Zhu, P., Zhang, X., Pan, Q., Gong, C., Huang, Y., Hu, X., Su, F., Lieberman, J., and Song, E. (2007) let-7 regulates self renewal and tumorigenicity of breast cancer cells Cell 131, 1109–23.
86. Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., and Brauch, H. (2005) Prevalence of CD44+/CD24-/ low cells in breast cancer may not be associated with clinical outcome but may favor distant metastasis Clin Cancer Res 11, 1154–9.
87. Balic, M., Lin, H., Young, L., Hawes, D., Giuliano, A., McNamara, G., Datar, R. H., and Cote, R. J. (2006) Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype Clin Cancer Res 12, 5615–21.
88. Chambers, A. F., Groom, A. C., and MacDonald, I. C. (2002) Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2, 563–72.
89. Chambers, A. F., Naumov, G. N., Varghese, H. J., Nadkarni, K. V., MacDonald, I. C., and Groom, A. C. (2001) Critical steps in hematogenous metastasis: an overview Surg Oncol Clin N Am 10, 243–55, vii.
90. Pantel, K. and Brakenhoff, R. H. (2004) Dissecting the metastatic cascade Nat Rev Cancer 4, 448–56.
91. Cameron, M. D., Schmidt, E. E., Kerkvliet, N., Nadkarni, K. V., Morris, V. L., Groom, A. C., Chambers, A. F., and MacDonald, I. C. (2000) Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency Cancer Res 60, 2541–6.
92. Luzzi, K. J., MacDonald, I. C., Schmidt, E. E., Kerkvliet, N., Morris, V. L., Chambers, A. F., and Groom, A. C. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases Am J Pathol 153, 865–73.
93. Weiss, L. (1990) Metastatic inefficiency Adv Cancer Res 54, 159–211.
94. Allan, A. L., Vantyghem, S. A., Tuck, A. B., and Chambers, A. F. (2006) Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis Breast Dis 26, 87–98.
95. Scadden, D. T. (2007) The stem cell niche in health and leukemic disease Best Pract Res Clin Haematol 20, 19–27.
96. Hendrix, M. J., Seftor, E. A., Seftor, R. E., Kasemeier-Kulesa, J., Kulesa, P. M., and Postovit, L. M. (2007) Reprogramming metastatic tumour cells with embryonic microenvironments Nat Rev Cancer 7, 246–55.
97. Chepko, G. and Dickson, R. B. (2003) Ultrastructure of the putative stem cell niche in rat mammary epithelium Tissue Cell 35, 83–93.
98. Burger, J. A. and Peled, A. (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers Leukemia 23, 43–52.
99. Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., Zhu, Z., Hicklin, D., Wu, Y., Port, J. L., Altorki, N., Port, E. R., Ruggero, D., Shmelkov, S. V., Jensen, K. K., Rafii, S., and Lyden, D. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche Nature 438, 820–7.
100. Psaila, B., Kaplan, R. N., Port, E. R., and Lyden, D. (2006) Priming the ‘soil’ for breast cancer metastasis: the pre-metastatic niche Breast Dis 26, 65–74.
101. Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., and Shibuya, M. (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis Cancer Cell 2, 289–300.
102. Hiratsuka, S., Watanabe, A., Sakurai, Y., Akashi-Takamura, S., Ishibashi, S., Miyake, K., Shibuya, M., Akira, S., Aburatani, H., and Maru, Y. (2008) The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase Nat Cell Biol 10, 1349–55.
103. Wicha, M. S., Liu, S., and Dontu, G. (2006) Cancer stem cells: an old idea--a paradigm shift Cancer Res 66, 1883–90; discussion 1895–6.
104. Li, L. and Neaves, W. B. (2006) Normal stem cells and cancer stem cells: the niche matters Cancer Res 66, 4553–7.
105. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., Ratajczak, J., and Ratajczak, M. Z. (2005) Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis Stem Cells 23, 879–94.
106. Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., and Ratajczak, J. (2006) The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis Leukemia 20, 1915–24.
107. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., and Weinberg, R. A. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121, 335–48.
108. Spoo, A. C., Lubbert, M., Wierda, W. G., and Burger, J. A. (2007) CXCR4 is a prognostic marker in acute myelogenous leukemia Blood 109, 786–91.
109. Rubin, J. B., Kung, A. L., Klein, R. S., Chan, J. A., Sun, Y., Schmidt, K., Kieran, M. W., Luster, A. D., and Segal, R. A. (2003) A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors Proc Natl Acad Sci USA 100, 13513–8.
110. Dewan, M. Z., Ahmed, S., Iwasaki, Y., Ohba, K., Toi, M., and Yamamoto, N. (2006) Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer Biomed Pharmacother 60, 273–6.
111. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., Barrera, J. L., Mohar, A., Verastegui, E., and Zlotnik, A. (2001) Involvement of chemokine receptors in breast cancer metastasis Nature 410, 50–6.
112. Liang, Z., Wu, T., Lou, H., Yu, X., Taichman, R. S., Lau, S. K., Nie, S., Umbreit, J., and Shim, H. (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4 Cancer Res 64, 4302–8.
113. Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., Halushka, M. K., Sukumar, S., Parker, L. M., Anderson, K. S., Harris, L. N., Garber, J. E., Richardson, A. L., Schnitt, S. J., Nikolsky, Y., Gelman, R. S., and Polyak, K. (2007) Molecular definition of breast tumor heterogeneity Cancer Cell 11, 259–73.
114. Tuck, A. B., Chambers, A. F., and Allan, A. L. (2007) Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management J Cell Biochem 102, 859–68.
115. Marhaba, R. and Zoller, M. (2004) CD44 in cancer progression: adhesion, migration and growth regulation J Mol Histol 35, 211–31.
116. Ponta, H., Sherman, L., and Herrlich, P. A. (2003) CD44: from adhesion molecules to signalling regulators Nat Rev Mol Cell Biol 4, 33–45.
117. Zen, K., Liu, D. Q., Guo, Y. L., Wang, C., Shan, J., Fang, M., Zhang, C. Y., and Liu, Y. (2008) CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration PLoS ONE 3, e1826.
118. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., Campbell, L. L., Polyak, K., Brisken, C., Yang, J., and Weinberg, R. A. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133, 704–15.
119. Fillmore, C. M. and Kuperwasser, C. (2008) Human breast cancer cell lines contain stem-like cells that self-renew, give rise to pheno-typically diverse progeny and survive chemotherapy Breast Cancer Res 10, R25.
120. Ponti, D., Costa, A., Zaffaroni, N., Pratesi, G., Petrangolini, G., Coradini, D., Pilotti, S., Pierotti, M. A., and Daidone, M. G. (2005) Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/ progenitor cell properties Cancer Res 65, 5506–11.
121. Sheridan, C., Kishimoto, H., Fuchs, R. K., Mehrotra, S., Bhat-Nakshatri, P., Turner, C. H., Goulet, R., Jr., Badve, S., and Nakshatri, H. (2006) CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis Breast Cancer Res 8, R59.
122. Liu, R., Wang, X., Chen, G. Y., Dalerba, P., Gurney, A., Hoey, T., Sherlock, G., Lewicki, J., Shedden, K., and Clarke, M. F. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells N Engl J Med 356, 217–26.
123. Honeth, G., Bendahl, P. O., Ringner, M., Saal, L. H., Gruvberger-Saal, S. K., Lovgren, K., Grabau, D., Ferno, M., Borg, A., and Hegardt, C. (2008) The CD44+/CD24-phenotype is enriched in basal-like breast tumors Breast Cancer Res 10, R53.
124. Li, C., Heidt, D. G., Dalerba, P., Burant, C. F., Zhang, L., Adsay, V., Wicha, M., Clarke, M. F., and Simeone, D. M. (2007) Identification of pancreatic cancer stem cells Cancer Res 67, 1030–7.
125. Zhang, S., Balch, C., Chan, M. W., Lai, H. C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H., and Nephew, K. P. (2008) Identification and characterization of ovarian cancer-initiating cells from primary human tumors Cancer Res 68, 4311–20.
126. Polyak, K. and Weinberg, R. A. (2009) Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits Nat Rev Cancer.
127. Thiery, J. P. and Sleeman, J. P. (2006) Complex networks orchestrate epithelial-mesenchymal transitions Nat Rev Mol Cell Biol 7, 131–42.
128. Yang, J. and Weinberg, R. A. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev Cell 14, 818–29.
129. Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., and Thompson, E. W. (2007) Epithelial--mesenchymal and mesenchymal--epithelial transitions in carcinoma progression J Cell Physiol 213, 374–83.
130. Eccles, S. A. and Welch, D. R. (2007) Metastasis: recent discoveries and novel treatment strategies Lancet 369, 1742–57.
131. Kang, Y. and Massague, J. (2004) Epithelial-mesenchymal transitions: twist in development and metastasis Cell 118, 277–9.
132. Stover, D. G., Bierie, B., and Moses, H. L. (2007) A delicate balance: TGF-beta and the tumor microenvironment J Cell Biochem 101, 851–61.
133. Moreno-Bueno, G., Portillo, F., and Cano, A. (2008) Transcriptional regulation of cell polarity in EMT and cancer Oncogene 27, 6958–69.
134. Peinado, H., Olmeda, D., and Cano, A. (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7, 415–28.
135. Morel, A. P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S., and Puisieux, A. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition PLoS ONE 3, e2888.